Mark R. Nilges

Endomorphin analog analgesics with reduced abuse liability, respiratory depression, motor impairment, tolerance, and glial activation relative to morphine

James E. Zadina, Mark R. Nilges, Jenny Morgenweck et al. · Neuropharmacology · 2015 · 92 citations

Medicine, Medicinal Chemistry, Pharmacology +17

Functional improvement in mouse models of familial amyotrophic lateral sclerosis by PEGylated insulin-like growth factor I treatment depends on disease severity

Stefanie Saenger, Bettina Holtmann, Mark R. Nilges et al. · Amyotrophic Lateral Sclerosis · 2012 · 27 citations

Life Sciences, Neurology, Neuroscience +17

Discriminative Stimulus and Low Abuse Liability Effects of Novel Endomorphin Analogs Suggest a Potential Treatment Indication for Opioid Use Disorder

Mark R. Nilges, Morgan Laurent, Chloe Cable et al. · Journal of Pharmacology and Experimental Therapeutics · 2019 · 10 citations · Full text

Medicine, Neuroscience, Pharmacology +13

Opioid-enhancing antinociceptive effects of delta-9-tetrahydrocannabinol and amitriptyline in rhesus macaques.

Mark R. Nilges, Zachary B. Bondy, Joseph Gracé et al. · Experimental and Clinical Psychopharmacology · 2019 · 10 citations

Medicine, Pharmacology, Neuropharmacology +16